J I Silverberg1, R Joks, H G Durkin. 1. Departments of Dermatology, Preventive Medicine and Medical Social Sciences, Northwestern University, Chicago, IL, USA; Department of Dermatology, Beth Israel Medical Center and St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
Abstract
BACKGROUND: Previous studies using animal models suggest an association between allergic disease and epilepsy. We sought to determine whether allergic disease is associated with epilepsy in children. METHODS: We used the 2007-2008 National Survey of Children's Health, a US population-based study of 91 642 children aged 0-17 years to determine the association between the prevalence of epilepsy and allergic disease, including asthma, atopic dermatitis (AD)/eczema, hay fever, and food allergies. Multivariate logistic regression models were constructed that controlled for confounding variables. RESULTS: The US lifetime prevalence of childhood epilepsy was 1.03% and was significantly associated with older age, male sex, lower household income, family structure and history of brain injury or concussion. Children with ≥1 allergic disease had more epilepsy in their lifetime than nonallergic children (logistic regression, adjusted odds ratio [95% confidence interval] = 1.79 [1.37-2.33]). Lifetime prevalence (2.30 [1.50-3.52]) and one-year prevalence of asthma (2.00 [1.41-2.84]), AD/eczema (1.73 [1.17-2.56]), hay fever (1.93 [1.41-2.65]) and food allergies (2.69 [1.38-4.01]) were associated with increased odds of ever being diagnosed with epilepsy. Similar results were found for current history of epilepsy. Severe AD/eczema (3.89 [1.34-11.32]) [corrected] and hay fever (2.46 [1.11-5.41]) were associated with even higher odds of epilepsy compared with mild/moderate disease. As the number of allergic diseases increased, so did the odds of lifetime history and current history of epilepsy. CONCLUSIONS: The US prevalence of epilepsy is associated with allergic diseases in children. Further studies are needed to determine whether allergic inflammation contributes toward epileptogenesis.
BACKGROUND: Previous studies using animal models suggest an association between allergic disease and epilepsy. We sought to determine whether allergic disease is associated with epilepsy in children. METHODS: We used the 2007-2008 National Survey of Children's Health, a US population-based study of 91 642 children aged 0-17 years to determine the association between the prevalence of epilepsy and allergic disease, including asthma, atopic dermatitis (AD)/eczema, hay fever, and food allergies. Multivariate logistic regression models were constructed that controlled for confounding variables. RESULTS: The US lifetime prevalence of childhood epilepsy was 1.03% and was significantly associated with older age, male sex, lower household income, family structure and history of brain injury or concussion. Children with ≥1 allergic disease had more epilepsy in their lifetime than nonallergic children (logistic regression, adjusted odds ratio [95% confidence interval] = 1.79 [1.37-2.33]). Lifetime prevalence (2.30 [1.50-3.52]) and one-year prevalence of asthma (2.00 [1.41-2.84]), AD/eczema (1.73 [1.17-2.56]), hay fever (1.93 [1.41-2.65]) and food allergies (2.69 [1.38-4.01]) were associated with increased odds of ever being diagnosed with epilepsy. Similar results were found for current history of epilepsy. Severe AD/eczema (3.89 [1.34-11.32]) [corrected] and hay fever (2.46 [1.11-5.41]) were associated with even higher odds of epilepsy compared with mild/moderate disease. As the number of allergic diseases increased, so did the odds of lifetime history and current history of epilepsy. CONCLUSIONS: The US prevalence of epilepsy is associated with allergic diseases in children. Further studies are needed to determine whether allergic inflammation contributes toward epileptogenesis.
Authors: Jonathan I Silverberg; Paras P Vakharia; Rishi Chopra; Ryan Sacotte; Neha Patel; Supriya Immaneni; Takeisha White; Robert Kantor; Derek Y Hsu Journal: J Allergy Clin Immunol Pract Date: 2017-11-10
Authors: Juho Joutsa; Juha O Rinne; Bruce Hermann; Mira Karrasch; Anu Anttinen; Shlomo Shinnar; Matti Sillanpää Journal: JAMA Neurol Date: 2017-05-01 Impact factor: 18.302
Authors: Paula Kauppi; Miika Linna; Juha Jantunen; Jaana E Martikainen; Tari Haahtela; Anna Pelkonen; Mika Mäkelä Journal: Mediators Inflamm Date: 2015-12-13 Impact factor: 4.711
Authors: Ingo Marenholz; Jorge Esparza-Gordillo; Franz Rüschendorf; Anja Bauerfeind; David P Strachan; Ben D Spycher; Hansjörg Baurecht; Patricia Margaritte-Jeannin; Annika Sääf; Marjan Kerkhof; Markus Ege; Svetlana Baltic; Melanie C Matheson; Jin Li; Sven Michel; Wei Q Ang; Wendy McArdle; Andreas Arnold; Georg Homuth; Florence Demenais; Emmanuelle Bouzigon; Cilla Söderhäll; Göran Pershagen; Johan C de Jongste; Dirkje S Postma; Charlotte Braun-Fahrländer; Elisabeth Horak; Ludmila M Ogorodova; Valery P Puzyrev; Elena Yu Bragina; Thomas J Hudson; Charles Morin; David L Duffy; Guy B Marks; Colin F Robertson; Grant W Montgomery; Bill Musk; Philip J Thompson; Nicholas G Martin; Alan James; Patrick Sleiman; Elina Toskala; Elke Rodriguez; Regina Fölster-Holst; Andre Franke; Wolfgang Lieb; Christian Gieger; Andrea Heinzmann; Ernst Rietschel; Thomas Keil; Sven Cichon; Markus M Nöthen; Craig E Pennell; Peter D Sly; Carsten O Schmidt; Anja Matanovic; Valentin Schneider; Matthias Heinig; Norbert Hübner; Patrick G Holt; Susanne Lau; Michael Kabesch; Stefan Weidinger; Hakon Hakonarson; Manuel A R Ferreira; Catherine Laprise; Maxim B Freidin; Jon Genuneit; Gerard H Koppelman; Erik Melén; Marie-Hélène Dizier; A John Henderson; Young Ae Lee Journal: Nat Commun Date: 2015-11-06 Impact factor: 14.919
Authors: Barbara Klein; Heike Mrowetz; Josef Thalhamer; Sandra Scheiblhofer; Richard Weiss; Ludwig Aigner Journal: Front Cell Neurosci Date: 2016-06-28 Impact factor: 5.505